Abstract
Advances in the treatment of inflammatory bowel disease (IBD) are published routinely in medical journals. Some treatments are sufficiently helpful that their conclusions are incorporated into clinical guidelines. However, such publications and proclamations may go unheeded among practitioners. Underuse, overuse, and misuse of clinical therapeutics, diagnostics, and routine medical processes are sufficiently prevalent among IBD practitioners that movements are afoot to determine the best methods for achieving a minimal uniformity of effective care. Such explorations are part of an effort to improve the quality of care. In this article, we review the background that has led to a push toward quality improvements in medicine in general, in gastroenterology in general, and within IBD specifically.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 87-94 |
| Number of pages | 8 |
| Journal | Current Gastroenterology Reports |
| Volume | 13 |
| Issue number | 1 |
| DOIs | |
| State | Published - Feb 1 2011 |
| Externally published | Yes |
Fingerprint
Keywords
- Crohn's disease
- Inflammatory bowel disease
- Practice variation
- Quality
- Quality indicators
- Quality initiatives
- Quality measurements
- Quality of care
- Ulcerative colitis
ASJC Scopus subject areas
- Gastroenterology
Cite this
Quality of care in inflammatory bowel disease. / Shah, Brijen; Tinsley, Andrew; Ullman, Thomas A.
In: Current Gastroenterology Reports, Vol. 13, No. 1, 01.02.2011, p. 87-94.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Quality of care in inflammatory bowel disease
AU - Shah, Brijen
AU - Tinsley, Andrew
AU - Ullman, Thomas A.
PY - 2011/2/1
Y1 - 2011/2/1
N2 - Advances in the treatment of inflammatory bowel disease (IBD) are published routinely in medical journals. Some treatments are sufficiently helpful that their conclusions are incorporated into clinical guidelines. However, such publications and proclamations may go unheeded among practitioners. Underuse, overuse, and misuse of clinical therapeutics, diagnostics, and routine medical processes are sufficiently prevalent among IBD practitioners that movements are afoot to determine the best methods for achieving a minimal uniformity of effective care. Such explorations are part of an effort to improve the quality of care. In this article, we review the background that has led to a push toward quality improvements in medicine in general, in gastroenterology in general, and within IBD specifically.
AB - Advances in the treatment of inflammatory bowel disease (IBD) are published routinely in medical journals. Some treatments are sufficiently helpful that their conclusions are incorporated into clinical guidelines. However, such publications and proclamations may go unheeded among practitioners. Underuse, overuse, and misuse of clinical therapeutics, diagnostics, and routine medical processes are sufficiently prevalent among IBD practitioners that movements are afoot to determine the best methods for achieving a minimal uniformity of effective care. Such explorations are part of an effort to improve the quality of care. In this article, we review the background that has led to a push toward quality improvements in medicine in general, in gastroenterology in general, and within IBD specifically.
KW - Crohn's disease
KW - Inflammatory bowel disease
KW - Practice variation
KW - Quality
KW - Quality indicators
KW - Quality initiatives
KW - Quality measurements
KW - Quality of care
KW - Ulcerative colitis
UR - http://www.scopus.com/inward/record.url?scp=79551535900&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79551535900&partnerID=8YFLogxK
U2 - 10.1007/s11894-010-0155-7
DO - 10.1007/s11894-010-0155-7
M3 - Article
C2 - 21080247
AN - SCOPUS:79551535900
VL - 13
SP - 87
EP - 94
JO - Current Gastroenterology Reports
JF - Current Gastroenterology Reports
SN - 1522-8037
IS - 1
ER -